ET-201

N/A

Report date: 2024/12/31 14:55:45

Base Information

Drug NameET-201
Drug Alias NameET-201L-ICON3
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEndometriosisOvarian NeoplasmsTriple Negative Breast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State UniversityYale University
China Registration ClassN/A

Develop Information

Active CompaniesEikonoklastes Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEndometriosisOvarian NeoplasmsTriple Negative Breast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A